Evolv Technologies Holdings, Inc. [Rocket]

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20
	10-K	10-K	10-K
Revenues:
UNITED STATES	53.8	22.3
Non-US	1.4	1.1
Total revenues	55.2	23.4	4.8
Revenue growth [+]	135.9%	388.9%
UNITED STATES	141.8%
Non-US	21.2%
Cost of goods sold	53.5	19.4	3.5
Gross profit	1.7	4.0	1.3
Gross margin	3.1%	17.2%	26.9%
Selling, general and administrative [+]	84.4	46.0	12.5
Sales and marketing	46.6	26.1	7.4
General and administrative	37.7	19.9	5.1
Research and development	18.8	11.5	15.7
Other operating expenses		-0.9
EBITDA [+]	-95.9	-49.6	-25.8
EBITDA growth	93.3%	92.1%
EBITDA margin	-173.8%	-212.1%	-539.8%
Depreciation and amortization	5.5	2.9	1.1
EBIT [+]	-101.4	-52.5	-26.9
EBIT growth	93.1%	95.3%
EBIT margin	-183.7%	-224.5%	-562.1%
Non-recurring items [+]	1.2	2.7
Asset impairment	1.2	1.9
Interest expense, net [+]	-2.5	6.1	0.4
Interest expense	0.7	6.1	0.4
Interest income	3.2
Other income (expense), net [+]	13.7	50.4	-0.1
Gain (loss) on debt retirement		-12.7	-0.1
Unrealized gain/loss on derivatives		-1.7
Change in fair value of warrants		-1.7
Other	-0.1	-0.6
Pre-tax income	-86.4	-10.9	-27.4
Income taxes	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%
Net income	-86.4	-10.9	-27.4
Net margin	-156.5%	-46.5%	-572.5%

Basic EPS [+]	($0.60)	($0.15)	($3.07)
Growth	295.3%	-95.0%
Diluted EPS [+]	($0.60)	($0.15)	($3.07)
Growth	295.3%	-95.0%

Shares outstanding (basic) [+]	143.9	71.7	8.9
Growth	100.7%	702.3%
Shares outstanding (diluted) [+]	143.9	71.7	8.9
Growth	100.7%	702.3%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.